ILUME

ARPA-H LIGHT · University of Arizona

In-situ Lymphatic Ultrasound Microbubble Enhancement

Making the lymphatic system visible.

Lymphatic imaging simplified: one injection, one scan. A contrast agent, activated by a dedicated ultrasound pulse sequence, on standard FDA-cleared ultrasound.

VisibleIn minutesAnywhere

The problem

The body's last invisible system

Medicine can image the heart, the brain, the arteries and the veins. The lymphatics have stayed dark. Lymphatic disease is treatable, but diagnosis comes so late that tissue has often scarred into stages nothing can reverse.

The disease is treatable. The delay is what's devastating.
1.2Mpeople in the US with a lymphedema diagnosis
3–5Mestimated true burden in the US, by advocacy-group estimates
<5%of patients ever reach specialized lymphatic imaging

Today's options

Every existing option lives where patients aren't

Lymphoscintigraphy

The nuclear medicine standard

Radioactive tracer, an hours-long exam and coarse resolution. Available only in hospital nuclear medicine departments.

Specialized center · ionizing radiation

ICG / NIR fluorescence

The research favorite

Clear images of the first 1–2 cm, but light cannot reach the deep and central lymphatics where clinical decisions are made.

Depth-limited · dedicated camera hardware

MR lymphangiography

The premium option

Detailed anatomy on scarce magnet time. No functional information, no bedside use, and no practical follow-up cadence.

Capital-intensive · specialized centers

Proven modalities, confined to centers most patients never reach.

The ILUME procedure

As routine as an ultrasound visit

ILUME condenses perfluorobutane (C4F10) microbubbles into liquid nanodroplets small enough to drain into the lymphatics. The imaging pulse turns them back into bright microbubbles only where the probe is looking.

Diagram: a gas-core microbubble is condensed into a liquid nanodroplet at manufacture, injected, and vaporized back into an echogenic microbubble by the ultrasound pulse at the imaging site.
  1. Inject

    Nanodroplets drain into the lymphatics. They are too small to be trapped and stay stable at body temperature.

  2. Activate

    The imaging pulse vaporizes the droplets into bright microbubbles exactly where the probe is aimed, inside the lymphatic compartment and not the blood vessels.

  3. Diagnose

    Quantitative flow, contractility and anatomy, in minutes, on standard FDA-cleared ultrasound.

Team Arizona

World authority. Contrast agent pioneer. Ultrasound innovator. Company builder.

The co-inventor of an FDA-approved ultrasound contrast agent, the inventor of the imaging physics, and the lead author of the field's diagnostic standard, working together for the first time.

Russell Witte

Russell Witte, PhD

Principal Investigator

Professor of Medical Imaging. Inventor of the ultrasound imaging technologies behind ILUME; leads the science.

Marlys Witte

Marlys Witte, MD

Co-Principal Investigator

Professor of Surgery. Secretary-General of the International Society of Lymphology and lead author of its lymphedema consensus.

Terry Matsunaga

Terry Matsunaga, PharmD, PhD

Co-Investigator

Professor of Biomedical Engineering. Co-inventor of Definity, the FDA-approved reference ultrasound contrast agent.

Mitchell J. Bartlett

Mitchell J. Bartlett, PhD

Co-Investigator, Discovery Duo JEDI

Director of the Lymphology-Surgical Biology Laboratory. Builds the disease models and testbeds ILUME is tested on.

Ken Coffey

Ken Coffey

Program Development Lead

MedTech executive who has taken multiple device programs from concept through regulatory clearance and exit.

Partner with us

Let's make the lymphatic system visible, for everyone.

ARPA-H LIGHT funds the science. We are building the partnerships that take ILUME from the lab to the clinic, and we would like to hear from you.

Get in touch

Tell us a little about your organization and what you would like to explore. The program team will reply directly.

Contact the ILUME team